$PDYN
Palladyne AI Corp.

2022 Q2 Form 10-Q Financial Statement

#000095017022009333 Filed on May 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $3.038M $743.0K $1.004M
YoY Change 165.79% -58.7%
Cost Of Revenue $3.146M $488.0K $1.060M
YoY Change 365.38% -59.4% -48.79%
Gross Profit -$108.0K $255.0K -$56.00K
YoY Change -123.13% -57.29% -104.12%
Gross Profit Margin -3.55% 34.32% -5.58%
Selling, General & Admin $20.73M $20.00M $21.47M
YoY Change 407.64% 573.5% 813.62%
% of Gross Profit 7844.31%
Research & Development $7.569M $5.881M $6.118M
YoY Change 86.7% 108.92% 113.17%
% of Gross Profit 2306.27%
Depreciation & Amortization $900.0K $300.0K $205.0K
YoY Change 310.96% 200.0% 86.36%
% of Gross Profit 117.65%
Operating Expenses $28.88M $25.88M $27.59M
YoY Change 254.82% 347.43% 6130566.67%
Operating Profit -$28.98M -$25.63M -$27.64M
YoY Change 277.83% 394.01% -2133.32%
Interest Expense $148.0K $11.00K -$4.000K
YoY Change -1238.46% -99.92% -80.0%
% of Operating Profit
Other Income/Expense, Net $4.111M $2.000K -$8.414M
YoY Change 14582.14%
Pretax Income -$24.72M -$19.20M -$34.06M
YoY Change 369.86% 269.41% 7569233.33%
Income Tax -$1.606M $0.00 $0.00
% Of Pretax Income
Net Earnings -$23.12M -$19.20M -$34.06M
YoY Change 339.26% 269.41% 7569233.33%
Net Earnings / Revenue -760.96% -2584.39% -3392.63%
Basic Earnings Per Share -$0.95 -$0.14
Diluted Earnings Per Share -$158.0K -$139.2K -$246.6K
COMMON SHARES
Basic Shares Outstanding 153.8M 142.9M 142.8M
Diluted Shares Outstanding 24.38M 137.9M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $152.8M $199.0M $217.1M
YoY Change 681.81% 51364.86%
Cash & Equivalents $73.26M $199.0M $217.1M
Short-Term Investments $79.51M
Other Short-Term Assets $5.512M $6.969M $9.202M
YoY Change 32.06% 1194.99%
Inventory $1.896M $1.005M $1.006M
Prepaid Expenses
Receivables $3.971M $800.0K $788.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $164.1M $207.9M $228.3M
YoY Change 539.14% 22380.78% 528.42%
LONG-TERM ASSETS
Property, Plant & Equipment $7.775M $6.841M $7.051M
YoY Change 76.66% 394.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $503.0K $460.0K $441.0K
YoY Change 2.44% -99.83% 51.03%
Total Long-Term Assets $99.87M $7.301M $7.492M
YoY Change 1941.39% -97.36% 336.34%
TOTAL ASSETS
Total Short-Term Assets $164.1M $207.9M $228.3M
Total Long-Term Assets $99.87M $7.301M $7.492M
Total Assets $264.0M $215.2M $235.8M
YoY Change 763.51% -22.3% 519.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.646M $1.629M $1.681M
YoY Change -19.51% 72.94%
Accrued Expenses $6.921M $3.867M $4.480M
YoY Change 557.89% 26.87% 256.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $9.779M $5.496M $6.161M
YoY Change 152.36% 80.32% 73.31%
LONG-TERM LIABILITIES
Long-Term Debt $5.000K $6.000K $7.000K
YoY Change -99.78%
Other Long-Term Liabilities $5.181M $1.988M $1.999M
YoY Change 242.21% -91.49% 280.04%
Total Long-Term Liabilities $5.186M $1.988M $1.999M
YoY Change 38.0% -91.49% 280.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.779M $5.496M $6.161M
Total Long-Term Liabilities $5.186M $1.988M $1.999M
Total Liabilities $17.73M $14.77M $21.86M
YoY Change 123.93% -44.07% 324.73%
SHAREHOLDERS EQUITY
Retained Earnings -$164.7M -$145.5M
YoY Change 127.39%
Common Stock $14.00K $14.00K
YoY Change 40.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $246.3M $200.4M $214.0M
YoY Change
Total Liabilities & Shareholders Equity $264.0M $215.2M $235.8M
YoY Change 763.51% -22.3% 519.76%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$23.12M -$19.20M -$34.06M
YoY Change 339.26% 269.41% 7569233.33%
Depreciation, Depletion And Amortization $900.0K $300.0K $205.0K
YoY Change 310.96% 200.0% 86.36%
Cash From Operating Activities -$15.47M -$12.45M -$21.20M
YoY Change 22.6% 221.67%
INVESTING ACTIVITIES
Capital Expenditures -$176.0K $514.0K -$1.649M
YoY Change -92.29% -46.57% -1199.33%
Acquisitions
YoY Change
Other Investing Activities -$109.2M
YoY Change
Cash From Investing Activities -$109.4M -$514.0K -$1.649M
YoY Change -139.96% -46.57% 999.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -857.0K -5.190M -1.230M
YoY Change -99.69% -385.32%
NET CHANGE
Cash From Operating Activities -15.47M -12.45M -21.20M
Cash From Investing Activities -109.4M -514.0K -1.649M
Cash From Financing Activities -857.0K -5.190M -1.230M
Net Change In Cash -125.7M -18.16M -24.07M
YoY Change 766.26% 502.39%
FREE CASH FLOW
Cash From Operating Activities -$15.47M -$12.45M -$21.20M
Capital Expenditures -$176.0K $514.0K -$1.649M
Free Cash Flow -$15.30M -$12.97M -$19.55M
YoY Change 47.97% 168.28% 12930.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001826681
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39897
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
SARCOS TECHNOLOGY AND ROBOTICS CORPORATION
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2838301
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
650 South 500 West
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84101
CY2022Q1 dei City Area Code
CityAreaCode
888
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
927-7296
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
153800000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198958000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
217114000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
800000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
788000
CY2022Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
159000
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
221000
CY2022Q1 us-gaap Inventory Net
InventoryNet
1005000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1006000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6969000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9202000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
207891000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
228331000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6841000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7051000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
460000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
441000
CY2022Q1 us-gaap Assets
Assets
215192000
CY2021Q4 us-gaap Assets
Assets
235823000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1629000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1681000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3867000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4480000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5496000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6161000
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
7283000
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
13701000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1988000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1999000
CY2022Q1 us-gaap Liabilities
Liabilities
14767000
CY2021Q4 us-gaap Liabilities
Liabilities
21861000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
139026245
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139026245
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
137722658
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
137722658
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
14000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
14000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
365104000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
359439000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164693000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145491000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
200425000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
213962000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
215192000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
235823000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
743000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1799000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
488000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
1202000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5881000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2815000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17792000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2314000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2211000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
656000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
26372000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
6987000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-25629000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5188000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10000
CY2022Q1 strc Gain Loss On Warrant Liability
GainLossOnWarrantLiability
6414000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19202000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5198000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19202000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5198000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
137908690
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
104059652
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32904000
CY2021Q1 strc Payments For Proceeds From Purchase Of Non Controlling Interest
PaymentsForProceedsFromPurchaseOfNonControllingInterest
-200000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
173000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-5198000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27699000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
213962000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10850000
CY2022Q1 strc Shares Repurchased For Payment Of Tax Withholdings And Other Value
SharesRepurchasedForPaymentOfTaxWithholdingsAndOtherValue
-5250000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
65000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-19202000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
200425000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19202000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5198000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10850000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
173000
CY2022Q1 us-gaap Depreciation
Depreciation
268000
CY2021Q1 us-gaap Depreciation
Depreciation
111000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6414000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
537000
CY2021Q1 strc Increase Decrease Accrued Transaction Fees
IncreaseDecreaseAccruedTransactionFees
1133000
CY2022Q1 strc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
6000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1198000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12452000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-985000
CY2022Q1 strc Increase Decrease In Unbilled Receivables Under Changes In Operating Assets
IncreaseDecreaseInUnbilledReceivablesUnderChangesInOperatingAssets
-62000
CY2021Q1 strc Increase Decrease In Unbilled Receivables Under Changes In Operating Assets
IncreaseDecreaseInUnbilledReceivablesUnderChangesInOperatingAssets
423000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
311000
CY2021Q1 strc Increase Decrease In Deferred Transactions Costs
IncreaseDecreaseInDeferredTransactionsCosts
1427000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2233000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1105000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
18000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
403000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
454000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-616000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3871000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
514000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
962000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-514000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-962000
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2000000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
65000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20000
CY2022Q1 strc Shares Repurchased For Payment Of Tax Withholdings
SharesRepurchasedForPaymentOfTaxWithholdings
5254000
CY2021Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
200000
CY2022Q1 strc Payment Of Obligations Under Capital Leases
PaymentOfObligationsUnderCapitalLeases
1000
CY2021Q1 strc Payment Of Obligations Under Capital Leases
PaymentOfObligationsUnderCapitalLeases
1000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5190000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1819000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18156000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3014000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217114000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33664000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
198958000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30650000
CY2021Q1 strc Purchase Of Property And Equipment Included In Accounts Payable
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable
45000
CY2021Q1 strc Leasehold Improvements Paid By Lessor
LeaseholdImprovementsPaidByLessor
424000
CY2021Q3 strc Right To Receive Exchange Ratio Of Common Stock
RightToReceiveExchangeRatioOfCommonStock
0.05129222424
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0001
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
199000000.0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
217100000
CY2022Q1 strc Retained Earning Accumlated Deficit
RetainedEarningAccumlatedDeficit
-164700000
CY2022Q1 strc Working Capital
WorkingCapital
202400000
CY2022Q1 us-gaap Revenues
Revenues
743000
CY2021Q1 us-gaap Revenues
Revenues
1799000
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
788000
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
221000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
94000
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
36000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12000
CY2022Q1 strc Increase Decrease Unbilled Receivable
IncreaseDecreaseUnbilledReceivable
-62000
CY2022Q1 strc Increase Decrease In Contract Assets Current
IncreaseDecreaseInContractAssetsCurrent
-43000
CY2022Q1 strc Increas Decrease In Contract Assets Long Term
IncreasDecreaseInContractAssetsLongTerm
0
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
CY2022Q1 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
800000
CY2022Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
159000
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
51000
CY2022Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
36000
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30000
CY2022Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0
CY2021Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1800000
CY2022Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
7283000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
13701000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
41000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
508000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
507000
CY2021Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
13701000
CY2022Q1 strc Warrant Liability Transferred Out Of Level Three
WarrantLiabilityTransferredOutOfLevelThree
-13701000
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
452000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
458000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
45000
CY2022Q1 us-gaap Inventory Net
InventoryNet
1005000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1006000
CY2022Q1 us-gaap Inventory Adjustments
InventoryAdjustments
300000
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
300000
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
3272000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
4786000
CY2022Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
333000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
171000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6969000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9202000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8345000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8287000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2511000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1825000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
406000
CY2022Q1 strc Legal Accrual
LegalAccrual
0
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1504000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1236000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6841000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7051000
CY2022Q1 us-gaap Depreciation
Depreciation
300000
CY2021Q1 us-gaap Depreciation
Depreciation
100000
CY2021Q4 strc Legal Accrual
LegalAccrual
520000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
779000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1263000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1043000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3867000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4480000
CY2022Q1 strc Capital Leases And Other
CapitalLeasesAndOther
6000
CY2021Q4 strc Capital Leases And Other
CapitalLeasesAndOther
7000
CY2022Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1982000
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1992000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1988000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1999000
CY2022Q1 strc Redemption Of Common Shares
RedemptionOfCommonShares
-23479970
CY2022Q1 strc Shares From Merger And Pipe Financing
SharesFromMergerAndPipeFinancing
32525990
CY2022Q1 strc Recapitalization Of Old Common Stock
RecapitalizationOfOldCommonStock
105063285
CY2022Q1 strc Net Impact To Additional Paid In Capital And Par Value Share
NetImpactToAdditionalPaidInCapitalAndParValueShare
137589275
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21483286
CY2021Q3 strc Business Combination Exchange Ratio
BusinessCombinationExchangeRatio
0.05129222424
CY2021Q1 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
200000
CY2020Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
250000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10027094
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.28
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
67173000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1010
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.81
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
83582
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.78
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
744907
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.21
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9199615
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.99
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
37590000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5176464
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.46
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
49268000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5296422
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.51
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
32547000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10850000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
173000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19202000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5198000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
137908690
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
104059652
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62564533
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13457486
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
961000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
970000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1323000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1360000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1397000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
9919000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15930000
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2022Q1 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
97000
CY2022Q1 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
4000
CY2022Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
4000
CY2022Q1 strc Minimum Lease Payment Including Interest
MinimumLeasePaymentIncludingInterest
105000
CY2022Q1 strc Amount Representing Interest
AmountRepresentingInterest
3000
CY2022Q1 strc Minimum Lease Payment Excluding Interest
MinimumLeasePaymentExcludingInterest
102000
CY2022Q1 us-gaap Recorded Unconditional Purchase Obligation Due Within One Year
RecordedUnconditionalPurchaseObligationDueWithinOneYear
8000000
CY2022Q1 us-gaap Recorded Unconditional Purchase Obligation Due In Second Year
RecordedUnconditionalPurchaseObligationDueInSecondYear
8000000
CY2022Q1 us-gaap Recorded Unconditional Purchase Obligation Due In Third Year
RecordedUnconditionalPurchaseObligationDueInThirdYear
10000000
CY2022Q1 us-gaap Recorded Unconditional Purchase Obligation Due In Fourth Year
RecordedUnconditionalPurchaseObligationDueInFourthYear
10000000
CY2022Q1 us-gaap Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
36000000
CY2022Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
800000
CY2022Q1 strc Defined Contribution Plan Maximum Deferred Compensation By Employees Percentage
DefinedContributionPlanMaximumDeferredCompensationByEmployeesPercentage
1
CY2021 strc Defined Contribution Plan Maximum Deferred Compensation By Employees Percentage
DefinedContributionPlanMaximumDeferredCompensationByEmployeesPercentage
1
CY2022Q1 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
0
CY2021Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
0

Files In Submission

Name View Source Status
0000950170-22-009333-index-headers.html Edgar Link pending
0000950170-22-009333-index.html Edgar Link pending
0000950170-22-009333.txt Edgar Link pending
0000950170-22-009333-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
strc-20220331.htm Edgar Link pending
strc-20220331.xsd Edgar Link pending
strc-20220331_cal.xml Edgar Link unprocessable
strc-20220331_def.xml Edgar Link unprocessable
strc-20220331_htm.xml Edgar Link completed
strc-20220331_lab.xml Edgar Link unprocessable
strc-20220331_pre.xml Edgar Link unprocessable
strc-ex10_2.htm Edgar Link pending
strc-ex31_1.htm Edgar Link pending
strc-ex31_2.htm Edgar Link pending
strc-ex32_1.htm Edgar Link pending
strc-ex32_2.htm Edgar Link pending